Project Grant R21EY036603
Award Date
9/30/24
Completion Date
9/29/26
Dollars Obligated
$347K
Federal Agency
National Eye Institute
Federal Grant Program
93.867
Assistance Type
Project Grant
Place of Performance
Snyder, NY 14215, USA
Similar Awards
The National Eye Institute (NEI), under the federal Vision Research program (CFDA 93.867), awarded a $684,891 Project Grant to the Massachusetts Eye and Ear Infirmary in Boston, MA. The grant will fund research to address the challenge of interpreting rare genetic variants associated with inherited retinal degenerations (IRDs), a leading cause of blindness. Specifically, the project aims to: Develop a high-throughput splicing assay to better understand how rare coding and non-coding variants can...
This Project Grant award from the National Eye Institute (NEI), under the Vision Research federal grant program (CFDA 93.867), supports research to elucidate the function of the MTRNR2L1 gene and explore its potential implications in the pathogenesis of neovascular age-related macular degeneration (NAMD). The $240,713 award, effective February 1, 2025 through January 31, 2027, will fund studies to determine if MTRNR2L1 is a protein-encoding gene or a long non-coding RNA, and to investigate its...
This Project Grant award from the National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), supports research to develop a novel, laser-based approach for non-viral corneal gene delivery. The $431,750 award to the University of California, Irvine aims to create microscale channels through the corneal epithelium to enhance transepithelial diffusion, and use femtosecond laser pulses to permeabilize stromal cells for plasmid-based gene delivery, without the risks associated...
This Project Grant award of $437,310, provided by the National Eye Institute (CFDA 93.867 Vision Research program), supports research to study the molecular and physiological mechanisms underlying retinal remodeling following photoreceptor degeneration. The key objectives are to elucidate the genetic, morphological, and physiological changes in retinal ganglion cells that lead to hyperactivity and corruption of visual circuits, with the goal of informing strategies to prevent or reverse...
This federal Project Grant award from the National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), is funding the development of OPGX-RHO, a single-vector gene therapy for the treatment of autosomal-dominant retinitis pigmentosa (ADRP). The $882,971 award supports two key objectives: 1) completing chemistry, manufacturing, and controls for a clinical-grade batch of OPGX-RHO, including stability studies and device compatibility testing, and 2) conducting efficacy and...
This is a Project Grant award from the National Eye Institute (NEI), under the Vision Research federal grant program (CFDA 93.867), in the amount of $249,000.00. The grant will fund research to investigate the molecular mechanisms that regulate the expression of phototransduction genes in mammalian rod photoreceptors. The research aims to elucidate how transcriptional elongation and mRNA processing are coupled to enhance the efficiency and accuracy of mRNA maturation, and how defects in these...
This federal Project Grant award from the National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), provides $226,135 to The University of Iowa to assess the in vivo efficacy, safety, and activity of an anticodon engineered transfer RNA (ACE-tRNA) in multiple ocular cell types for the treatment of hereditary eye diseases caused by nonsense mutations. The research aims to evaluate the ability of the ACE-tRNA to rescue diseases like pigment dispersing iris disease and...
This Project Grant award, provided by the National Eye Institute (NEI) under the Vision Research federal grant program (CFDA 93.867), supports research to understand how the retina adapts to photoreceptor loss in retinal degeneration. The $624,230 award to the University of California, Los Angeles (UCLA) spans May 1, 2025 to April 30, 2029. The research aims to document changes in rod photoreceptor function and connectivity as degeneration progresses, as well as investigate plasticity in retinal...
This federal Project Grant award of $477,109.00, provided by the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867), supports research to determine how the transcriptional regulator PRDM13 regulates retinal development and its association with North Carolina macular dystrophy. The overarching goal is to further the understanding of mammalian retinal development by establishing the mechanisms by which PRDM13 guides cell fate decisions, and how these contribute to healthy...
This Project Grant award from the National Eye Institute (NEI), under the Vision Research federal grant program (CFDA 93.867), will fund research at the University of California, San Francisco (UCSF) to study the neural mechanisms of sensory encoding after photoreceptor degeneration. The $237,588 award, effective June 1, 2025 through December 31, 2027, will leverage the vertical optokinetic reflex, a visual behavior that tracks global motion, to investigate how cone degeneration disrupts noise...